The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence
The Oncology Institute (TOI) has joined Lantern's specialty care platform, expanding access to cancer care for Lantern members across TOI's community clinics in 5 states. The partnership aims to provide advanced cancer treatment while reducing financial burden for patients. TOI, with over 120 clinicians and 700 team members across 70+ clinic locations, serves a population of over 1.8 million patients. The collaboration focuses on delivering optimal outcomes and patient satisfaction through value-based oncology care, including clinical trials and transfusion services.
L'Istituto di Oncologia (TOI) si è unito alla piattaforma di assistenza specialistica di Lantern, ampliando l'accesso alle cure oncologiche per i membri di Lantern nelle cliniche comunitarie di TOI in 5 stati. L'obiettivo della partnership è fornire trattamenti oncologici avanzati riducendo al contempo il carico finanziario per i pazienti. TOI conta oltre 120 clinici e 700 membri del team in più di 70 sedi cliniche, servendo una popolazione di oltre 1,8 milioni di pazienti. La collaborazione si concentra sull'offerta di risultati ottimali e soddisfazione dei pazienti attraverso un'assistenza oncologica basata sul valore, incluse prove cliniche e servizi di trasfusione.
El Instituto de Oncología (TOI) se ha unido a la plataforma de atención especializada de Lantern, ampliando el acceso a la atención del cáncer para los miembros de Lantern en las clínicas comunitarias de TOI en 5 estados. La asociación tiene como objetivo proporcionar tratamientos oncológicos avanzados mientras se reduce la carga financiera para los pacientes. TOI, con más de 120 clínicos y 700 miembros del equipo en más de 70 ubicaciones clínicas, atiende a una población de más de 1.8 millones de pacientes. La colaboración se centra en ofrecer resultados óptimos y satisfacción del paciente a través de una atención oncológica basada en el valor, incluidas ensayos clínicos y servicios de transfusión.
온콜로지 연구소(TOI)는 랜턴의 전문 치료 플랫폼에 합류하여 TOI 지역 클리닉이 있는 5개 주의 랜턴 회원에게 암 치료 접근성을 확장했습니다. 이 파트너십의 목표는 환자의 경제적 부담을 줄이면서 고급 암 치료를 제공하는 것입니다. TOI는 120명이 넘는 임상의와 700명의 팀원이 70개 이상의 클리닉 위치에서 근무하며 180만 명 이상의 환자에게 서비스를 제공합니다. 이 협력은 임상 시험 및 수혈 서비스를 포함하여 가치 기반의 온콜로지 치료를 통해 최적의 결과와 환자 만족도를 제공하는 데 중점을 두고 있습니다.
L'Institut d'oncologie (TOI) a rejoint la plateforme de soins spécialisés de Lantern, élargissant l'accès aux soins du cancer pour les membres de Lantern dans les cliniques communautaires de TOI dans 5 états. Ce partenariat vise à fournir des traitements avancés contre le cancer tout en réduisant le fardeau financier des patients. TOI, qui compte plus de 120 cliniciens et 700 membres au sein de son équipe dans plus de 70 sites cliniques, sert une population de plus de 1,8 million de patients. La collaboration se concentre sur l'offre de résultats optimaux et de satisfaction des patients grâce à des soins oncologiques basés sur la valeur, y compris des essais cliniques et des services de transfusion.
Das Onkologieinstitut (TOI) hat sich der spezialisierten Pflegeplattform von Lantern angeschlossen und erweitert den Zugang zur Krebsversorgung für Lantern-Mitglieder in den Gemeinschaftskliniken von TOI in 5 Bundesstaaten. Ziel der Partnerschaft ist es, fortgeschrittene Krebsbehandlungen anzubieten und gleichzeitig die finanzielle Belastung für die Patienten zu verringern. TOI beschäftigt über 120 Kliniker und 700 Teammitglieder an mehr als 70 Klinikstandorten und betreut eine Bevölkerung von über 1,8 Millionen Patienten. Die Zusammenarbeit konzentriert sich darauf, optimale Ergebnisse und Patientenzufriedenheit durch wertbasierte Onkologieversorgung zu liefern, einschließlich klinischer Studien und Transfusionsdienste.
- Partnership with Lantern expands TOI's market reach and patient access
- Large operational scale with 70+ clinic locations across 5 states
- Serves substantial patient base of 1.8 million patients
- Strong workforce with 120+ clinicians and 700+ team members
- None.
Insights
The partnership between TOI and Lantern represents a strategic move in the value-based healthcare sector, but its immediate financial impact appears While TOI gains access to Lantern's 6 million members across the country, the deal's terms and revenue potential remain undisclosed. TOI's extensive network of 70+ clinic locations and coverage of 1.8 million patients suggests solid infrastructure for scaling, but without specific financial projections or deal terms, the partnership's material impact on TOI's bottom line is uncertain.
The collaboration aligns with broader healthcare industry trends toward value-based care models and specialized provider networks. However, the gradual nature of healthcare network integration and patient adoption patterns suggests this will be a long-term growth driver rather than a near-term catalyst for TOI's stock.
CERRITOS, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, has joined Lantern’s leading specialty care platform. Now, Lantern members will have access to cancer care at any of The Oncology Institute’s state-of-the-art community clinics across 5 states.
“At TOI, we believe that every cancer patient deserves access to the most advanced care in their community,” said Dr. Dan Virnich, Chief Executive Officer of TOI. “We are excited to be part of Lantern’s network, offering a new cancer care option for employers that prioritizes optimal outcomes, patient satisfaction, and reduces the financial burden often associated with cancer treatment, all in alignment with our mission and the needs of the community.”
“A cancer diagnosis can be one of the most overwhelming moments in healthcare, and our goal is to help employers connect their employees with the best cancer care, when they need it most,” said Nicki MacManus, SVP and General Manager of Cancer Care at Lantern. “Our focus at Lantern has always been to provide employees with access to the top performing specialty care providers, and we are proud to partner with a group like TOI that shares in our commitment to excellence and accessibility.”
About Lantern
Lantern is the specialty care platform connecting people with the best care when they need it most. By curating a Network of Excellence comprised of the nation’s top specialists for surgery, cancer care, infusions and more, Lantern delivers excellent care with significant cost savings to employers and their workforces. Lantern also pairs members with a dedicated care team, including Care Advocates and nurses, for the entirety of their care journey, helping them get back to good health, back to their families and back to work. With convenient access to specialists nationwide, Lantern means quality care is within driving distance for most. Lantern is trusted by the nation’s largest employers to deliver care to more than 6 million members across the country. Learn more about us at lanterncare.com.
About TOI
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
FAQ
What is the significance of TOI joining Lantern's Cancer Care Network?
How many clinic locations does TOI (NASDAQ: TOI) currently operate?
What is the current patient population served by The Oncology Institute (TOI)?
